Mylan has launched a biosimilar version of Sanofi’s best-selling insulin, Lantus, that it says is priced 65 percent lower than comparable insulins. The biosimilar, called Semglee, costs $147.98 for a ...

Mylan and Pfizer have spent years defending their marketing of the popular epinephrine injector EpiPen. After a busy couple of months in court, the partners have now wiped their hands of another ...

Consumers traditionally have been blamed for drug pollution entering the ecosystem through urine or flushing unused drugs down the drain, but pollution from drug manufacturing facilities is actually ...

STATEWIDE — New York Attorney General Letitia James’ office has helped to secure a multistate settlement in principle with the successor company of pharmaceutical manufacturer Mylan Inc. that will ...

Mylan Pharmaceuticals is pulling a batch of Xanax from pharmacy shelves nationwide because of what the company said is "the potential presence of a foreign substance" in the popular prescription ...

PITTSBURGH — Mylan has launched a generic drug for fungal infections, the company said Tuesday. Mylan announced the launch, through subsidiary Mylan Pharmaceuticals, of voriconazole tablets in the ...

Teva Pharmaceutical is facing down plenty of lawsuits. Now, one of its chief rivals in the generics field is adding another case to Teva's plate. Mylan, which has merged with Pfizer's Upjohn to form ...

PITTSBURGH — Mylan on Friday announced that its subsidiary, Mylan Pharmaceuticals, has received final approval from the U.S. Food and Drug Administration for its phenytoin chewable tablets USP in the ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. CLEVELAND – For the second time in a little ...